The Difference Between Cystatin C– and Creatinine-Based eGFR in Heart Failure With Reduced Ejection Fraction: Insights From PARADIGM-HF
The clinical implications of the discrepancy between cystatin C (cysC)– and serum creatinine (Scr)–estimated glomerular filtration rate (eGFR) in patients with heart failure (HF) and reduced ejection fraction (HFrEF) are unknown.
